WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 18'6001 Infant (under 12 months) mortality rate: 182
GDP / capita (US$): 32'5971 Child (under 5 years) mortality rate: 202

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 1'365  1'360  1'354  1'348  1'342  1'268  1'222  1'085 
Births 19  19  19  20  20  19  25  31 
Surviving infants 18  19  19  19  19  18  25  30 
Pop. less than 5 years 95  96  97  98  98  90  133  132 
Pop. less than 15 years 283  283  282  280  278  324  410  369 
Female 15-49 years 352  353  355  358  361  353  314  282 

Number of reported cases

(Click for retrospective incidence data for Trinidad and Tobago)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  511  384 
Mumps
ChartChart
 
Pertussis
ChartChart
  10 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  10  28 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Trinidad and Tobago)
Vaccine year result method % card seen                                                
BCG         
DTP1          97  91  93  94  87  90 
DTP3          97  96  92  92  92  90  82  26 
DTP4          82  84  75 
IPV1          96  99*  67 
HepB_BD         
HepB3          97  90  92  92  92 
Hib3          97  90  92  92  92  74 
JapEnc         
MCV1          86  89  96  91  85  90  71 
MCV2          65  79  93  86  85 
MenA         
PCV1          98  87  94  91  81 
PCV2          98  98  94  90  64 
PCV3          91  95  80  39 
Pol3          84  88  94  94  91  90  87  38 
Rota1         
RotaC         
RCV1          86  96  91  86 
TT2plus          14  89  14  15  14 
PAB         
VAD1         
YFV          85  91  96  89  85 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Trinidad and Tobago)
DTP1
ChartChart
  97  98  93  94  97  90  94  51 
DTP3
ChartChart
  97  96  92  92  92  90  82  26 
HepB3
ChartChart
  97  90  92  92  92 
HepB_BD
ChartChart
 
Hib3
ChartChart
  97  90  92  92  92  74 
IPV1
  96 
MCV1
ChartChart
  86  89  96  91  85  90  70 
MCV2
ChartChart
  65  79  93  86  85 
PCV3
ChartChart
  91  93  95  80  39 
Pol3
ChartChart
  84  88  94  94  91  90  87  38 
RCV1
ChartChart
  86  89  96  91  85  90  70 
RotaC
 
YFV
ChartChart
  85  91  96  89  85  91 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 107  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 7
From 80 to 89% 1
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
92
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTwP 18 months; 5 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB_Adult 10 years; +2, +6 months; Yes adolescents and adults
HPV >= 11 years; +2, +6 months; Yes
Influenza_Adult >= 60 years; Yes Adults with chronic diseases, pregnant women, health care workers and other risk groups
Influenza_Pediatric 6 months - 17 years; Yes children with chronic diseases
IPV 2, 4, 6 months; Yes
MMR 12 months; 4-5 years; Yes
OPV 4, 6, 18 months; 4-5 years; Yes
Pneumo_conj 2, 4, 6, 18 months; Yes
Pneumo_ps >= 24 months; Yes
Td >7 years; Yes
Varicella >= 12 months; No at risk
YF 1 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number NA    2016-2018  2013-2014  2012 -2013  2011-2012  2010-2011 
Nº of districts with microplans that include activities to raise immunization coverage number

System performance

Total Nº districts in country number 107 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  89  89 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 22  67  44  33  56  56 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  No  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  13    95  100    100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  No  No  No    No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.